Callan Family Office’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NTR
VCM
Callan Family Office's NTR Position: Q1 2026 in Review
Callan Family Office reduced its Nutrien (NTR) stake by 1.2% in Q1 2026, selling an estimated $9.48K and leaving 10,951 shares worth $825K. The position accounts for 0.02% of the portfolio, ranked #614.
Callan Family Office first reported a position in NTR in Q4 2025 and has held it in 2 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Callan Family Office held 10,951 shares of Nutrien worth $825K as of Q1 2026.
- Callan Family Office sold 133 Nutrien shares in Q1 2026, an estimated $9.48K.
- Nutrien made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #614 holding.
- Callan Family Office first reported a position in Nutrien in Q4 2025 and has held it in 2 quarters since.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.